Bessemer Group
KMTS

Bessemer Group’s Kestra Medical Technologies KMTS Stock Holding History

Bessemer Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Buy
520
+69
+15% +$1.45K ﹤0.01% 2110
2026
Q1 		$9K Buy
451
+102
+29% +$2.4K ﹤0.01% 2153
2025
Q4 		$9K Buy
349
+120
+52% +$3.09K ﹤0.01% 2145
2025
Q3 		$5K Buy
229
+140
+157% +$2.5K ﹤0.01% 2165
2025
Q2 		$1K Hold
89
– – ﹤0.01% 2375
2025
Q1 		$2K Buy
+89
New +$2.04K ﹤0.01% 2293

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bessemer Group's KMTS Position: Q2 2026 in Review

Bessemer Group increased its Kestra Medical Technologies (KMTS) stake by 15% in Q2 2026, buying an estimated $1.45K and bringing the position to 520 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

Bessemer Group first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Bessemer Group held 520 shares of Kestra Medical Technologies worth $13K as of Q2 2026.
  • Bessemer Group bought 69 Kestra Medical Technologies shares in Q2 2026, an estimated $1.45K.
  • Kestra Medical Technologies made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2110 holding.
  • Bessemer Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.